Being used, under special circumstances, as a medical treatment of AATD in the so-called “replacement” therapy (consisting in the intravenous infusion of the missing protein), AAT is a molecule with a lot of therapeutic importance. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.